Form SD EAGLE MATERIALS INC
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM SD
SPECIALIZED DISCLOSURE REPORT
EAGLE MATERIALS INC.
(Exact name of registrant as specified in its charter)
Delaware
(State of Incorporation)
1-12984
(Commission File No.)
75-2520779
(I.R.S. Employer Identification No.)
5960 Berkshire Lane, Suite 900, Dallas, Texas 75225
(Address of principal executive offices)
Matt Newby, (214) 432-2000
(Name and telephone number, including area code, of the person to contact in connection with this report.)
Check the appropriate box to indicate the rule pursuant to which this form is being filed and provide the period to which the information in this form applies:
| ☐ | Rule 13p-1 under the Securities Exchange Act (17 CFR 240.13p-1) for the reporting period from April 1, 2025 to March 31, 2026 |
| ☒ | Rule 13q-1 under the Securities Exchange Act (17 CFR 240.13q-1) for the fiscal year ended March 31, 2026 |
Section 2 – Resource Extraction Issuer Disclosure
Item 2.01 Resource Extraction Issuer Disclosure Report
Disclosure of Payments by Resource Extraction Issuer
The specified payment disclosure required by Form SD is included in Exhibit 2.01 hereto.
Section 3 – Exhibits
Item 3.01 Exhibits
The following exhibit is furnished as part of this report.
2.01 Disclosure of payments by resource extraction issuer for the fiscal year ended March 31, 2026
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the duly authorized undersigned.
| Eagle Materials Inc. | ||||||
| Date: August 4, 2026 | By: | /s/ Matt Newby | ||||
| Name: | Matt Newby | |||||
| Title | Executive Vice President, General Counsel and Secretary | |||||
ATTACHMENTS / EXHIBITS
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Eagle Materials (EXP) Declares $0.25 Quarterly Dividend; 0.5% Yield
- Summerwell Marvida Offers Single-Family, Townhome Rental Living where Cypress Meets Katy
- CoreAge Rx Addresses Stubborn Hyperpigmentation with Localized ‘Spot On’ Compound
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share